Found 1 matching record:
HXB2 Location | Gag(263-272) | Gag Epitope Map
View variants at this location |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KRWIILGLNK
|
Epitope Alignment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variants |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epitope Name | KK10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Species (MHC/HLA) | human(B*27:05) |
Showing all: 148 variant(s).
Variant ID. | 4707 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {n}KRWIILGLNK |
Mutations | Y/N |
Epitope Location | Y-1N |
HXB2 Location | Y262N |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, nKRWIILGLNK (-1 to the start of epitope KK10) had a decreased replicative capacity. |
Variant ID. | 4708 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {d}KRWIILGLNK |
Mutations | Y/D |
Epitope Location | Y-1D |
HXB2 Location | Y262D |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, dKRWIILGLNK (-1 to the start of epitope KK10) had a substantially decreased replicative capacity. |
Variant ID. | 4709 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {s}KRWIILGLNK |
Mutations | Y/S |
Epitope Location | Y-1S |
HXB2 Location | Y262S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, sKRWIILGLNK (-1 to the start of epitope KK10) had a substantially decreased replicative capacity. |
Variant ID. | 4710 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {p}KRWIILGLNK |
Mutations | Y/P |
Epitope Location | Y-1P |
HXB2 Location | Y262P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, pKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4711 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {i}KRWIILGLNK |
Mutations | Y/I |
Epitope Location | Y-1I |
HXB2 Location | Y262I |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, iKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4712 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {w}KRWIILGLNK |
Mutations | Y/W |
Epitope Location | Y-1W |
HXB2 Location | Y262W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, wKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4713 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {k}KRWIILGLNK |
Mutations | Y/K |
Epitope Location | Y-1K |
HXB2 Location | Y262K |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, kKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4714 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {a}KRWIILGLNK |
Mutations | Y/A |
Epitope Location | Y-1A |
HXB2 Location | Y262A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, aKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4715 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {m}KRWIILGLNK |
Mutations | Y/M |
Epitope Location | Y-1M |
HXB2 Location | Y262M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, mKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4716 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {l}KRWIILGLNK |
Mutations | Y/L |
Epitope Location | Y-1L |
HXB2 Location | Y262L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, lKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4717 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {r}KRWIILGLNK |
Mutations | Y/R |
Epitope Location | Y-1R |
HXB2 Location | Y262R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, rKRWIILGLNK (-1 to the start of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4718 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {q}KRWIILGLNK |
Mutations | Y/Q |
Epitope Location | Y-1Q |
HXB2 Location | Y262Q |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, qKRWIILGLNK (-1 to the start of epitope KK10) had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4719 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {e}KRWIILGLNK |
Mutations | Y/E |
Epitope Location | Y-1E |
HXB2 Location | Y262E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, eKRWIILGLNK (-1 to the start of epitope KK10) had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4720 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {v}KRWIILGLNK |
Mutations | Y/V |
Epitope Location | Y-1V |
HXB2 Location | Y262V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, vKRWIILGLNK (-1 to the start of epitope KK10) had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4721 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {t}KRWIILGLNK |
Mutations | Y/T |
Epitope Location | Y-1T |
HXB2 Location | Y262T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, tKRWIILGLNK (-1 to the start of epitope KK10) had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4722 |
---|---|
Epitope Seq. | {Y}KRWIILGLNK |
Variant Seq. | {g}KRWIILGLNK |
Mutations | Y/G |
Epitope Location | Y-1G |
HXB2 Location | Y262G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, gKRWIILGLNK (-1 to the start of epitope KK10) had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4723 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{l} |
Mutations | I/L |
Epitope Location | I+1L |
HXB2 Location | I273L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKl (+1 to the end of epitope KK10) had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4724 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{r} |
Mutations | I/R |
Epitope Location | I+1R |
HXB2 Location | I273R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKr (+1 to the end of epitope KK10) had at least a 2-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4725 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{k} |
Mutations | I/K |
Epitope Location | I+1K |
HXB2 Location | I273K |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKk (+1 to the end of epitope KK10) had at least a 5-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4726 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{v} |
Mutations | I/V |
Epitope Location | I+1V |
HXB2 Location | I273V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKv (+1 to the end of epitope KK10) had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4727 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{t} |
Mutations | I/T |
Epitope Location | I+1T |
HXB2 Location | I273T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKt (+1 to the end of epitope KK10) had a decreased replicative capacity. |
Variant ID. | 4728 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{m} |
Mutations | I/M |
Epitope Location | I+1M |
HXB2 Location | I273M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKm (+1 to the end of epitope KK10) had a decreased replicative capacity. |
Variant ID. | 4729 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{c} |
Mutations | I/C |
Epitope Location | I+1C |
HXB2 Location | I273C |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKc (+1 to the end of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4730 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{w} |
Mutations | I/W |
Epitope Location | I+1W |
HXB2 Location | I273W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKw (+1 to the end of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4731 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{p} |
Mutations | I/P |
Epitope Location | I+1P |
HXB2 Location | I273P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKp (+1 to the end of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4732 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{s} |
Mutations | I/S |
Epitope Location | I+1S |
HXB2 Location | I273S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKs (+1 to the end of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4733 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{q} |
Mutations | I/Q |
Epitope Location | I+1Q |
HXB2 Location | I273Q |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKq (+1 to the end of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4734 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{g} |
Mutations | I/G |
Epitope Location | I+1G |
HXB2 Location | I273G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKg (+1 to the end of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4735 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNa |
Mutations | K/A |
Epitope Location | K10A |
HXB2 Location | K272A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNa had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4736 |
---|---|
Epitope Seq. | KRWIILGLNK{I} |
Variant Seq. | KRWIILGLNK{a} |
Mutations | I/A |
Epitope Location | I+1A |
HXB2 Location | I273A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNKa (+1 to the end of epitope KK10) had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4737 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRlIILGLNK |
Mutations | W/L |
Epitope Location | W3L |
HXB2 Location | W265L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRlIILGLNK had a slightly increased replicative capacity but did not have an increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs. |
Variant ID. | 4738 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRcIILGLNK |
Mutations | W/C |
Epitope Location | W3C |
HXB2 Location | W265C |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRcIILGLNK had a slightly increased replicative capacity but did not have an increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs. |
Variant ID. | 4739 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIiGLNK |
Mutations | L/I |
Epitope Location | L6I |
HXB2 Location | L268I |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIiGLNK had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs. |
Variant ID. | 4740 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIImGLNK |
Mutations | L/M |
Epitope Location | L6M |
HXB2 Location | L268M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIImGLNK had at least a 2-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs. |
Variant ID. | 4741 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWvILGLNK |
Mutations | I/V |
Epitope Location | I4V |
HXB2 Location | I266V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWvILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, and only a moderate reduction in replicative capacity. This suggests escape mutant potential as defined by the authors. |
Variant ID. | 4742 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIvGLNK |
Mutations | L/V |
Epitope Location | L6V |
HXB2 Location | L268V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIvGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs and only a moderate reduction in replicative capacity. This suggests escape mutant potential as defined by the authors. |
Variant ID. | 4743 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KnWIILGLNK |
Mutations | R/N |
Epitope Location | R2N |
HXB2 Location | R264N |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KnWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs and only a moderate reduction in replicative capacity. This suggests escape mutant potential as defined by the authors. |
Variant ID. | 4744 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIpGLNK |
Mutations | L/P |
Epitope Location | L6P |
HXB2 Location | L268P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIpGLNK had a decreased replicative capacity. |
Variant ID. | 4745 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILwLNK |
Mutations | G/W |
Epitope Location | G7W |
HXB2 Location | G269W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILwLNK had a decreased replicative capacity. |
Variant ID. | 4746 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILvLNK |
Mutations | G/V |
Epitope Location | G7V |
HXB2 Location | G269V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILvLNK had a decreased replicative capacity. |
Variant ID. | 4747 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILeLNK |
Mutations | G/E |
Epitope Location | G7E |
HXB2 Location | G269E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILeLNK had a decreased replicative capacity. |
Variant ID. | 4748 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILrLNK |
Mutations | G/R |
Epitope Location | G7R |
HXB2 Location | G269R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILrLNK had a decreased replicative capacity. |
Variant ID. | 4749 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRrIILGLNK |
Mutations | W/R |
Epitope Location | W3R |
HXB2 Location | W265R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRrIILGLNK had a decreased replicative capacity. |
Variant ID. | 4750 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRsIILGLNK |
Mutations | W/S |
Epitope Location | W3S |
HXB2 Location | W265S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRsIILGLNK had a decreased replicative capacity. |
Variant ID. | 4751 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWtILGLNK |
Mutations | I/T |
Epitope Location | I4T |
HXB2 Location | I266T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWtILGLNK had a decreased replicative capacity. |
Variant ID. | 4752 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | nRWIILGLNK |
Mutations | K/N |
Epitope Location | K1N |
HXB2 Location | K263N |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, nRWIILGLNK had a decreased replicative capacity. |
Variant ID. | 4753 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | eRWIILGLNK |
Mutations | K/E |
Epitope Location | K1E |
HXB2 Location | K263E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, eRWIILGLNK had a decreased replicative capacity. |
Variant ID. | 4754 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGsNK |
Mutations | L/S |
Epitope Location | L8S |
HXB2 Location | L270S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGsNK had a decreased replicative capacity. |
Variant ID. | 4755 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGpNK |
Mutations | L/P |
Epitope Location | L8P |
HXB2 Location | L270P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGpNK had a decreased replicative capacity. |
Variant ID. | 4756 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KmWIILGLNK |
Mutations | R/M |
Epitope Location | R2M |
HXB2 Location | R264M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KmWIILGLNK had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4757 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNe |
Mutations | K/E |
Epitope Location | K10E |
HXB2 Location | K272E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNe had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4758 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNr |
Mutations | K/R |
Epitope Location | K10R |
HXB2 Location | K272R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNr had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4759 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | rRWIILGLNK |
Mutations | K/R |
Epitope Location | K1R |
HXB2 Location | K263R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, rRWIILGLNK had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4760 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRgIILGLNK |
Mutations | W/G |
Epitope Location | W3G |
HXB2 Location | W265G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRgIILGLNK had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4761 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIrGLNK |
Mutations | L/R |
Epitope Location | L6R |
HXB2 Location | L268R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIrGLNK had at least a 2-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4762 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIItGLNK |
Mutations | L/T |
Epitope Location | L6T |
HXB2 Location | L268T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIItGLNK had at least a 2-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4763 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLkK |
Mutations | N/K |
Epitope Location | N9K |
HXB2 Location | N271K |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLkK had at least a 2-fold to 5-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4764 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIvLGLNK |
Mutations | I/V |
Epitope Location | I5V |
HXB2 Location | I267V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIvLGLNK had at least a 2-fold to 5-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4765 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILaLNK |
Mutations | G/A |
Epitope Location | G7A |
HXB2 Location | G269A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILaLNK had at least a 2-fold to 5-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4766 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGvNK |
Mutations | L/V |
Epitope Location | L8V |
HXB2 Location | L270V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGvNK had at least a 2-fold to 5-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4767 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGmNK |
Mutations | L/M |
Epitope Location | L8M |
HXB2 Location | L270M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGmNK had at least a 2-fold to 5-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4768 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGwNK |
Mutations | L/W |
Epitope Location | L8W |
HXB2 Location | L270W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGwNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4769 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KkWIILGLNK |
Mutations | R/K |
Epitope Location | R2K |
HXB2 Location | R264K |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KkWIILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4770 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KcWIILGLNK |
Mutations | R/C |
Epitope Location | R2C |
HXB2 Location | R264C |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KcWIILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4771 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWaILGLNK |
Mutations | I/A |
Epitope Location | I4A |
HXB2 Location | I266A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWaILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4772 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIlLGLNK |
Mutations | I/L |
Epitope Location | I5L |
HXB2 Location | I267L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIlLGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4773 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIfGLNK |
Mutations | L/F |
Epitope Location | L6F |
HXB2 Location | L268F |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIfGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4774 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIqGLNK |
Mutations | L/Q |
Epitope Location | L6Q |
HXB2 Location | L268Q |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIqGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4775 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIwGLNK |
Mutations | L/W |
Epitope Location | L6W |
HXB2 Location | L268W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIwGLNK had at least a 2-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4776 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLsK |
Mutations | N/S |
Epitope Location | N9S |
HXB2 Location | N271S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLsK had at least a 2-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4777 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWItLGLNK |
Mutations | I/T |
Epitope Location | I5T |
HXB2 Location | I267T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWItLGLNK had at least a 10-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4778 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KwWIILGLNK |
Mutations | R/W |
Epitope Location | R2W |
HXB2 Location | R264W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KwWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4779 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KgWIILGLNK |
Mutations | R/G |
Epitope Location | R2G |
HXB2 Location | R264G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KgWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4780 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KtWIILGLNK |
Mutations | R/T |
Epitope Location | R2T |
HXB2 Location | R264T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KtWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4781 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KsWIILGLNK |
Mutations | R/S |
Epitope Location | R2S |
HXB2 Location | R264S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KsWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4782 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KaWIILGLNK |
Mutations | R/A |
Epitope Location | R2A |
HXB2 Location | R264A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KaWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4783 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KqWIILGLNK |
Mutations | R/Q |
Epitope Location | R2Q |
HXB2 Location | R264Q |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KqWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4784 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KlWIILGLNK |
Mutations | R/L |
Epitope Location | R2L |
HXB2 Location | R264L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KlWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Variant ID. | 4785 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWImLGLNK |
Mutations | I/M |
Epitope Location | I5M |
HXB2 Location | I267M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWImLGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4786 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIcLGLNK |
Mutations | I/C |
Epitope Location | I5C |
HXB2 Location | I267C |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIcLGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4787 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIcGLNK |
Mutations | L/C |
Epitope Location | L6C |
HXB2 Location | L268C |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIcGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4788 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIsGLNK |
Mutations | L/S |
Epitope Location | L6S |
HXB2 Location | L268S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIsGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4789 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIaGLNK |
Mutations | L/A |
Epitope Location | L6A |
HXB2 Location | L268A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIaGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4790 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIsGLlK |
Mutations | L/S N/L |
Epitope Location | L6S N9L |
HXB2 Location | L268S N271L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIsGLlK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4791 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIqGLaK |
Mutations | L/Q N/A |
Epitope Location | L6Q N9A |
HXB2 Location | L268Q N271A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIqGLaK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4792 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIInGLiK |
Mutations | L/N N/I |
Epitope Location | L6N N9I |
HXB2 Location | L268N N271I |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIInGLiK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4793 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLgK |
Mutations | N/G |
Epitope Location | N9G |
HXB2 Location | N271G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLgK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4794 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLqK |
Mutations | N/Q |
Epitope Location | N9Q |
HXB2 Location | N271Q |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLqK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4795 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLhK |
Mutations | N/H |
Epitope Location | N9H |
HXB2 Location | N271H |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLhK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4796 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLtK |
Mutations | N/T |
Epitope Location | N9T |
HXB2 Location | N271T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLtK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity without CTLs. |
Variant ID. | 4797 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWlILGLNK |
Mutations | I/L |
Epitope Location | I4L |
HXB2 Location | I266L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWlILGLNK had at least a 10-fold increase in relative enrichment, when cultured with 1 of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4798 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWcILGLNK |
Mutations | I/C |
Epitope Location | I4C |
HXB2 Location | I266C |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWcILGLNK had at least a 2-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4799 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIsLGLNK |
Mutations | I/S |
Epitope Location | I5S |
HXB2 Location | I267S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIsLGLNK had at least a 2-fold to 5-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4800 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWsILGLNK |
Mutations | I/S |
Epitope Location | I4S |
HXB2 Location | I266S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWsILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4801 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWrILGLNK |
Mutations | I/R |
Epitope Location | I4R |
HXB2 Location | I266R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWrILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4802 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRaIILGLNK |
Mutations | W/A |
Epitope Location | W3A |
HXB2 Location | W265A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRaIILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4803 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIgLGLNK |
Mutations | I/G |
Epitope Location | I5G |
HXB2 Location | I267G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIgLGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4804 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIaLGLNK |
Mutations | I/A |
Epitope Location | I5A |
HXB2 Location | I267A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIaLGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4805 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KeWIILGLNK |
Mutations | R/E |
Epitope Location | R2E |
HXB2 Location | R264E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KeWIILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4806 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNt |
Mutations | K/T |
Epitope Location | K10T |
HXB2 Location | K272T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNt had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4807 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | hRWIILGLNK |
Mutations | K/H |
Epitope Location | K1H |
HXB2 Location | K263H |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, hRWIILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4808 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | vRWIILGLNK |
Mutations | K/V |
Epitope Location | K1V |
HXB2 Location | K263V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, vRWIILGLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4809 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILtLNK |
Mutations | G/T |
Epitope Location | G7T |
HXB2 Location | G269T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILtLNK had at least a 5-fold to 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4810 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | eRWIILGLNK |
Mutations | K/E |
Epitope Location | K1E |
HXB2 Location | K263E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, eRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4811 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | fRWIILGLNK |
Mutations | K/F |
Epitope Location | K1F |
HXB2 Location | K263F |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, fRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4812 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | dRWIILGLNK |
Mutations | K/D |
Epitope Location | K1D |
HXB2 Location | K263D |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, dRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4813 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | sRWIILGLNK |
Mutations | K/S |
Epitope Location | K1S |
HXB2 Location | K263S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, sRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4814 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | pRWIILGLNK |
Mutations | K/P |
Epitope Location | K1P |
HXB2 Location | K263P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, pRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4815 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | wRWIILGLNK |
Mutations | K/W |
Epitope Location | K1W |
HXB2 Location | K263W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, wRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4816 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | cRWIILGLNK |
Mutations | K/C |
Epitope Location | K1C |
HXB2 Location | K263C |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, cRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4817 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | lRWIILGLNK |
Mutations | K/L |
Epitope Location | K1L |
HXB2 Location | K263L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, lRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4818 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | aRWIILGLNK |
Mutations | K/A |
Epitope Location | K1A |
HXB2 Location | K263A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, aRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4819 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | sRWIILGLNK |
Mutations | K/S |
Epitope Location | K1S |
HXB2 Location | K263S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, sRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4820 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | qRWIILGLNK |
Mutations | K/Q |
Epitope Location | K1Q |
HXB2 Location | K263Q |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, qRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4821 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | gRWIILGLNK |
Mutations | K/G |
Epitope Location | K1G |
HXB2 Location | K263G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, gRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4822 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | mRWIILGLNK |
Mutations | K/M |
Epitope Location | K1M |
HXB2 Location | K263M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, mRWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4823 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KpWIILGLNK |
Mutations | R/P |
Epitope Location | R2P |
HXB2 Location | R264P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KpWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity without CTLs. |
Variant ID. | 4824 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KvWIILGLNK |
Mutations | R/V |
Epitope Location | R2V |
HXB2 Location | R264V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KvWIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4825 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRvIILGLNK |
Mutations | W/V |
Epitope Location | W3V |
HXB2 Location | W265V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRvIILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4826 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWpILGLNK |
Mutations | I/P |
Epitope Location | I4P |
HXB2 Location | I266P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWpILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4827 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWwILGLNK |
Mutations | I/W |
Epitope Location | I4W |
HXB2 Location | I266W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWwILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4828 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWgILGLNK |
Mutations | I/G |
Epitope Location | I4G |
HXB2 Location | I266G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWgILGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4829 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIrLGLNK |
Mutations | I/R |
Epitope Location | I5R |
HXB2 Location | I267R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIrLGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4830 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIkGLNK |
Mutations | L/K |
Epitope Location | L6K |
HXB2 Location | L268K |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIkGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity without CTLs. |
Variant ID. | 4831 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNe |
Mutations | K/E |
Epitope Location | K10E |
HXB2 Location | K272E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNe had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity without CTLs. |
Variant ID. | 4832 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIeGLNK |
Mutations | L/E |
Epitope Location | L6E |
HXB2 Location | L268E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIeGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4833 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIIgGLNK |
Mutations | L/G |
Epitope Location | L6G |
HXB2 Location | L268G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIIgGLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4834 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILlLNK |
Mutations | G/L |
Epitope Location | G7L |
HXB2 Location | G269L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILlLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4835 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILsLNK |
Mutations | G/S |
Epitope Location | G7S |
HXB2 Location | G269S |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILsLNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4836 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGtNK |
Mutations | L/T |
Epitope Location | L8T |
HXB2 Location | L270T |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGtNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4837 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGeNK |
Mutations | L/E |
Epitope Location | L8E |
HXB2 Location | L270E |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGeNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4838 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGgNK |
Mutations | L/G |
Epitope Location | L8G |
HXB2 Location | L270G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGgNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4839 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGaNK |
Mutations | L/A |
Epitope Location | L8A |
HXB2 Location | L270A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGaNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4840 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGrNK |
Mutations | L/R |
Epitope Location | L8R |
HXB2 Location | L270R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGrNK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4841 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLpK |
Mutations | N/P |
Epitope Location | N9P |
HXB2 Location | N271P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLpK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4842 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLwK |
Mutations | N/W |
Epitope Location | N9W |
HXB2 Location | N271W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLwK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4843 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLvK |
Mutations | N/V |
Epitope Location | N9V |
HXB2 Location | N271V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLvK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4844 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLaK |
Mutations | N/A |
Epitope Location | N9A |
HXB2 Location | N271A |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLaK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4845 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLlK |
Mutations | N/L |
Epitope Location | N9L |
HXB2 Location | N271L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLlK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4846 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLrK |
Mutations | N/R |
Epitope Location | N9R |
HXB2 Location | N271R |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLrK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4847 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNm |
Mutations | K/M |
Epitope Location | K10M |
HXB2 Location | K272M |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNm had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4848 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNv |
Mutations | K/V |
Epitope Location | K10V |
HXB2 Location | K272V |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNv had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4849 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNp |
Mutations | K/P |
Epitope Location | K10P |
HXB2 Location | K272P |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNp had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4850 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNl |
Mutations | K/L |
Epitope Location | K10L |
HXB2 Location | K272L |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNl had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4851 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNq |
Mutations | K/Q |
Epitope Location | K10Q |
HXB2 Location | K272Q |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNq had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4852 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNw |
Mutations | K/W |
Epitope Location | K10W |
HXB2 Location | K272W |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNw had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4853 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLNg |
Mutations | K/G |
Epitope Location | K10G |
HXB2 Location | K272G |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLNg had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a substantially decreased replicative capacity. |
Variant ID. | 4856 |
---|---|
Epitope Seq. | KRWIILGLNK |
Variant Seq. | KRWIILGLmK |
Mutations | I/K |
Epitope Location | I+1K |
HXB2 Location | I273K |
Mutation Type | |
Epitope Subtype | B |
Variant Subtype | B |
Method | Other, Relative replication capacity assay |
Note | Relative to consensus variant, KRWIILGLmK had at least a 10-fold increase in relative enrichment, when cultured with each of 2 KRWIILGLNK-specific CTL clones, vs. without CTLs, but also had a decreased replicative capacity. |
Gorin2017 Aleksandr M. Gorin, Yushen Du, Franklin Y. Liu, Tian-Hao Zhang, Hwee L. Ng, Christian Hofmann, William G. Cumberland, Ren Sun, and Otto O. Yang. HIV-1 Epitopes Presented by MHC Class I Types Associated with Superior Immune Containment of Viremia Have Highly Constrained Fitness Landscapes. PLoS Pathog, 13(8):e1006541, Aug 2017. PubMed ID: 28787455. Show all entries for this paper.
This is a legacy search page. It is deprecated, will receive no more updates, and will eventually be removed. Please use the new search pages.